205 related articles for article (PubMed ID: 15051798)
41. Differential recognition of ACE inhibitors in Xenopus laevis oocytes expressing rat PEPT1 and PEPT2.
Zhu T; Chen XZ; Steel A; Hediger MA; Smith DE
Pharm Res; 2000 May; 17(5):526-32. PubMed ID: 10888303
[TBL] [Abstract][Full Text] [Related]
42. Substrates of the human oligopeptide transporter hPEPT2.
Zhao D; Lu K
Biosci Trends; 2015 Aug; 9(4):207-13. PubMed ID: 26355221
[TBL] [Abstract][Full Text] [Related]
43. Delivery aspects of small peptides and substrates for peptide transporters.
Steffansen B; Nielsen CU; Frokjaer S
Eur J Pharm Biopharm; 2005 Jul; 60(2):241-5. PubMed ID: 15908190
[TBL] [Abstract][Full Text] [Related]
44. Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1.
Luckner P; Brandsch M
Eur J Pharm Biopharm; 2005 Jan; 59(1):17-24. PubMed ID: 15567297
[TBL] [Abstract][Full Text] [Related]
45. Di/tri-peptide transporters as drug delivery targets: regulation of transport under physiological and patho-physiological conditions.
Nielsen CU; Brodin B
Curr Drug Targets; 2003 Jul; 4(5):373-88. PubMed ID: 12816347
[TBL] [Abstract][Full Text] [Related]
46. Functional expression of stereoselective metabolism of cephalexin by exogenous transfection of oligopeptide transporter PEPT1.
Mitsuoka K; Kato Y; Kubo Y; Tsuji A
Drug Metab Dispos; 2007 Mar; 35(3):356-62. PubMed ID: 17142565
[TBL] [Abstract][Full Text] [Related]
47. Recent advances in structural biology of peptide transporters.
Terada T; Inui K
Curr Top Membr; 2012; 70():257-74. PubMed ID: 23177989
[TBL] [Abstract][Full Text] [Related]
48. Transport of L-proline, L-proline-containing peptides and related drugs at mammalian epithelial cell membranes.
Brandsch M
Amino Acids; 2006 Sep; 31(2):119-36. PubMed ID: 16622594
[TBL] [Abstract][Full Text] [Related]
49. Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Biegel A; Gebauer S; Hartrodt B; Brandsch M; Neubert K; Thondorf I
J Med Chem; 2005 Jun; 48(13):4410-9. PubMed ID: 15974593
[TBL] [Abstract][Full Text] [Related]
50. Peptide transporters: structure, function, regulation and application for drug delivery.
Terada T; Inui K
Curr Drug Metab; 2004 Feb; 5(1):85-94. PubMed ID: 14965252
[TBL] [Abstract][Full Text] [Related]
51. Expression of transporters potentially involved in the targeting of cytostatic bile acid derivatives to colon cancer and polyps.
Ballestero MR; Monte MJ; Briz O; Jimenez F; Gonzalez-San Martin F; Marin JJ
Biochem Pharmacol; 2006 Sep; 72(6):729-38. PubMed ID: 16844096
[TBL] [Abstract][Full Text] [Related]
52. Thiodipeptides targeting the intestinal oligopeptide transporter as a general approach to improving oral drug delivery.
Foley DW; Pathak RB; Phillips TR; Wilson GL; Bailey PD; Pieri M; Senan A; Meredith D
Eur J Med Chem; 2018 Aug; 156():180-189. PubMed ID: 30006163
[TBL] [Abstract][Full Text] [Related]
53. Oseltamivir (tamiflu) is a substrate of peptide transporter 1.
Ogihara T; Kano T; Wagatsuma T; Wada S; Yabuuchi H; Enomoto S; Morimoto K; Shirasaka Y; Kobayashi S; Tamai I
Drug Metab Dispos; 2009 Aug; 37(8):1676-81. PubMed ID: 19439487
[TBL] [Abstract][Full Text] [Related]
54. Expression of the mammalian renal peptide transporter PEPT2 in the yeast Pichia pastoris and applications of the yeast system for functional analysis.
Döring F; Michel T; Rösel A; Nickolaus M; Daniel H
Mol Membr Biol; 1998; 15(2):79-88. PubMed ID: 9724926
[TBL] [Abstract][Full Text] [Related]
55. Human PEPT1 pharmacophore distinguishes between dipeptide transport and binding.
Vig BS; Stouch TR; Timoszyk JK; Quan Y; Wall DA; Smith RL; Faria TN
J Med Chem; 2006 Jun; 49(12):3636-44. PubMed ID: 16759105
[TBL] [Abstract][Full Text] [Related]
56. Glycans in the intestinal peptide transporter PEPT1 contribute to function and protect from proteolysis.
Stelzl T; Geillinger-Kästle KE; Stolz J; Daniel H
Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G580-G591. PubMed ID: 28336547
[TBL] [Abstract][Full Text] [Related]
57. Frog intestinal sac as an in vitro method for the assessment of intestinal permeability in humans: Application to carrier transported drugs.
Franco M; Lopedota A; Trapani A; Cutrignelli A; Meleleo D; Micelli S; Trapani G
Int J Pharm; 2008 Mar; 352(1-2):182-8. PubMed ID: 18055143
[TBL] [Abstract][Full Text] [Related]
58. Physiological and pharmacological implications of peptide transporters, PEPT1 and PEPT2.
Inui K; Terada T; Masuda S; Saito H
Nephrol Dial Transplant; 2000; 15 Suppl 6():11-3. PubMed ID: 11143972
[TBL] [Abstract][Full Text] [Related]
59. Role and relevance of peptide transporter 2 (PEPT2) in the kidney and choroid plexus: in vivo studies with glycylsarcosine in wild-type and PEPT2 knockout mice.
Ocheltree SM; Shen H; Hu Y; Keep RF; Smith DE
J Pharmacol Exp Ther; 2005 Oct; 315(1):240-7. PubMed ID: 15987832
[TBL] [Abstract][Full Text] [Related]
60. Comparison of human and monkey peptide transporters: PEPT1 and PEPT2.
Zhang EY; Emerick RM; Pak YA; Wrighton SA; Hillgren KM
Mol Pharm; 2004; 1(3):201-10. PubMed ID: 15981923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
